Clinical Trials Logo

Clinical Trial Summary

Anxiety disorders commonly begin during adolescence, and are characterized by deficits in the ability to inhibit or extinguish pathological fear. Recent research has provided new understanding of how fear is learned and can be regulated in the adolescent brain, and how the endocannabinoid system shapes these processes; however, these advances have not yet translated into improved therapeutic outcomes for adolescents with anxiety. This study will test whether a behavioral intervention, acute exercise, can help to improve fear regulation by enhancing brain activity and endocannabinoid signaling. This line of research may ultimately lead to more effect treatments for adolescent anxiety, and to new preventive strategies for at-risk youth.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06297278
Study type Interventional
Source Wayne State University
Contact
Status Recruiting
Phase N/A
Start date May 1, 2024
Completion date April 30, 2028

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03977181 - The Community PrEP Study to Assess the Acceptance of PrEP Delivered Through CBCT Platforms N/A
Completed NCT01577498 - Age Estimation of Adolescents for Legal Purposes N/A
Recruiting NCT05726812 - Plan My Life Together; a Group Training for Adolescents With ADHD
Recruiting NCT04921215 - Teen Sleep and Light Study N/A
Completed NCT04824326 - The Effects of Pythagorean Self-Awareness Intervention on Young Adolescents in Primary School-Α One Arm Clinical Trial N/A
Completed NCT06112717 - The Application of the Self Care Deficit Nursing Theory in Adolescents With Cystic Fibrosis N/A
Recruiting NCT04753190 - Light Timing Study N/A
Active, not recruiting NCT01666912 - Postpartum Etonogestrel Implant for Adolescents Phase 4
Completed NCT04321785 - Effects of Caffeine on Sleep-wake Regulation in Teenagers N/A